scorecardresearch
Add as a preferred source on Google
Thursday, November 6, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Expert panel of India’s drug regulator recommends approval for Bharat Biotech’s Covaxin

The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation on Saturday deliberated on the emergency use authorisation application of Bharat Biotech.

Covid protection with placebo too? Bharat Biotech’s pitch for volunteers raises concerns

Bharat Biotech has asked Covaxin trial sites to offer Covid protection as an incentive to draw volunteers. Experts say it is unethical.

Bharat Biotech ‘thousands of volunteers short’ for ongoing Covaxin Phase 3 trials

Trial sites conducting Covaxin study say the company has given them an indicative deadline of 31 December to complete the recruitment of volunteers, but company denies claim.

Covaxin Phase 2 trials find Covid vaccine safe, no serious adverse events reported

Researchers, however, said evaluation of safety outcomes required extensive phase 3 clinical trials of the Covid vaccine developed through partnership between ICMR & Bharat Biotech.

Govt looks into new vaccine data after Pfizer, Bharat Biotech, SII seek emergency use approval

Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.

‘How do we get there?’ – Bharat Biotech readies for uphill task of Covid vaccine roll out

Bharat Biotech has already produced about 10 million doses of Covaxin shot, ahead of anticipated roll out next year. But task of supplying it seems daunting.

Covaxin Phase I trial results show vaccine is safe, generates immune response

In a preprint paper, researchers from Bharat Biotech, ICMR, AIIMS have reported the results of the trial on 375 participants. 

Expert panel seeks additional data on Covid vaccines from Serum Institute, Bharat Biotech

The applications of Bharat Biotech and Serum Institute of India are under consideration, while that of the Indian arm of Pfizer has not yet been taken up.

Over 60 foreign envoys visit Bharat Biotech, Biological E to see Covid vaccine progress

The Ambassadors and High Commissioners visited the facilities of the major pharma companies, which are involved in the manufacturing of Covid vaccine candidate, Covaxin.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

On Camera

Why Indian and American Hindus must adapt in a proselytising world

Indian sampradayas have to institutionalise their knowledge and boil it down to essentials for transmission and proselytisation if they are to compete with the major Abrahamic sects.

What does NCLAT order mean for data-sharing ban, penalty imposed by CCI on Meta & WhatsApp

On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.